Publication | Closed Access
A Phase II Study of Weekly Docetaxel in Combination with Capecitabine in Advanced Gastric and Gastroesophageal Adenocarcinomas
19
Citations
21
References
2010
Year
The regimen of docetaxel and capecitabine is a well-tolerated, easily administered and active outpatient regimen for advanced gastric and GE adenocarcinoma.
| Year | Citations | |
|---|---|---|
Page 1
Page 1